DiaMedica Therapeutics Inc. Common Stock

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell DMAC and other ETFs, options, and stocks.

About DMAC

DiaMedica Therapeutics, Inc. operates as a clinical stage biopharmaceutical company, which engages in the development of novel recombinant proteins. It develops the DM199 product candidate, which focuses on acute ischemic stroke (AIS) and chronic kidney disease (CKD). 

CEO
Rick John Pauls
CEORick John Pauls
Employees
28
Employees28
Headquarters
Minneapolis, Minnesota
HeadquartersMinneapolis, Minnesota
Founded
2000
Founded2000
Employees
28
Employees28

DMAC Key Statistics

Market cap
176.68M
Market cap176.68M
Price-Earnings ratio
-6.40
Price-Earnings ratio-6.40
Dividend yield
—
Dividend yield—
Average volume
115.46K
Average volume115.46K
High today
—
High today—
Low today
—
Low today—
Open price
$4.22
Open price$4.22
Volume
0.00
Volume0.00
52 Week high
$6.82
52 Week high$6.82
52 Week low
$2.14
52 Week low$2.14

People also own

Based on the portfolios of people who own DMAC. This list is generated using Robinhood data, and it’s not a recommendation.
NIO
SNDL
Plug Power
FuelCell Energy
Lucid Group
Tilray Brands
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.